Your browser doesn't support javascript.
loading
Deconstructing 14-phenylpropyloxymetopon: minimal requirements for binding to mu opioid receptors.
Stavitskaya, Lidiya; Shim, Jihyun; Healy, Jason R; Matsumoto, Rae R; MacKerell, Alexander D; Coop, Andrew.
Afiliación
  • Stavitskaya L; Dept. of Phar. Sci., Univ. of MD, School of Pharmacy, 20 N. Pine Street, Baltimore, MD 21201, USA.
Bioorg Med Chem ; 20(14): 4556-63, 2012 Jul 15.
Article en En | MEDLINE | ID: mdl-22677527
ABSTRACT
A series of phenylpropyloxyethylamines and cinnamyloxyethylamines were synthesized as deconstructed analogs of 14-phenylpropyloxymetopon and analyzed for opioid receptor binding affinity. Using the Conformationally Sampled Pharmacophore modeling approach, we discovered a series of compounds lacking a tyrosine mimetic, historically considered essential for µ opioid binding. Based on the binding studies, we have identified the optimal analogs to be N-methyl-N-phenylpropyl-2-(3-phenylpropoxy)ethanamine, with 1520 nM, and 2-(cinnamyloxy)-N-methyl-N-phenethylethanamine with 1680 nM affinity for the µ opioid receptor. These partial opioid structure analogs will serve as the novel lead compounds for future optimization studies.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Morfolinas / Receptores Opioides mu / Etilaminas Tipo de estudio: Prognostic_studies Idioma: En Año: 2012 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Morfolinas / Receptores Opioides mu / Etilaminas Tipo de estudio: Prognostic_studies Idioma: En Año: 2012 Tipo del documento: Article